Teza Capital Management LLC Agios Pharmaceuticals, Inc. Transaction History

Teza Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 10, 2021	SELL	$41.92 - $58.18 $254,915 - $353,792	-6,081 Closed	0 $0
Q2 2021 Aug 06, 2021	BUY	$52.06 - $61.27 $316,576 - $372,582	6,081 New	6,081 $335,000
Q3 2020 Nov 12, 2020	SELL	$33.87 - $55.93 $439,429 - $725,635	-12,974 Closed	0 $0
Q2 2020 Aug 10, 2020	BUY	$34.45 - $53.48 $446,954 - $693,849	12,974 New	12,974 $694,000
Q1 2020 May 11, 2020	SELL	$31.52 - $53.81 $631,188 - $1.08 Million	-20,025 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$30.08 - $50.59 $602,352 - $1.01 Million	20,025 New	20,025 $956,000

232

58.1M

403K

469K

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $3.24B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

Get notified when there are updates to the investment portfolio of Teza Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Teza Capital Management LLC with notifications on news.